Allogene Therapeutics, Inc.ALLONASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank25
3Y CAGR-10.5%
5Y CAGR-2.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-10.5%/yr
vs +17.9%/yr prior
5Y CAGR
-2.7%/yr
Recent deceleration
Acceleration
-28.5pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $56.78M | -12.9% |
| 2024 | $65.20M | -9.0% |
| 2023 | $71.67M | -9.6% |
| 2022 | $79.31M | +7.0% |
| 2021 | $74.11M | +13.6% |
| 2020 | $65.26M | +13.5% |
| 2019 | $57.47M | +40.2% |
| 2018 | $40.98M | +2049000.0% |
| 2017 | $2000.00 | - |